Neervannan Seshadri 4
4 · Tarsus Pharmaceuticals, Inc. · Filed Mar 19, 2026
Research Summary
AI-generated summary of this filing
Tarsus (TARS) COO Neervannan Seshadri Sells Shares
What Happened
Neervannan Seshadri, Chief Operating Officer of Tarsus Pharmaceuticals, sold a total of 11,324 shares in three open-market transactions between March 17–19, 2026. The sales were: 3,125 shares at $69.42 ($216,938) on 2026-03-17; 3,610 shares at $68.71 ($248,043) on 2026-03-18; and 4,589 shares at $67.00 ($307,463) on 2026-03-19, for aggregate proceeds of approximately $772,444. These sales were reported on a Form 4 filed March 19, 2026.
Key Details
- Transaction dates & prices:
- 2026-03-17: 3,125 shares @ $69.42 — $216,938
- 2026-03-18: 3,610 shares @ $68.71 — $248,043
- 2026-03-19: 4,589 shares @ $67.00 — $307,463
- Total shares sold: 11,324; total proceeds ≈ $772,444.
- Shares owned after the transactions: Not stated on this Form 4.
- Footnotes:
- F1: The sales were "sell-to-cover" transactions to satisfy tax withholding obligations connected to the vesting/settlement of Restricted Stock Units; the sales were mandated by the issuer and not discretionary by the reporting person.
- F2: A holding balance referenced in the filing relates to the reporting person’s daughter who shares his household; the reporting person disclaims beneficial ownership of those securities.
- Filing: Form 4 filed 2026-03-19 (covers transactions 3/17–3/19).
Context
These were sell-to-cover sales tied to RSU vesting (tax-related), which are routine and do not necessarily indicate a change in the insider’s view of the company. For retail investors, purchases can be more informative about insider sentiment; mandated tax-withholding sales are common and typically not interpreted as a discretionary bearish signal.
Insider Transaction Report
- Sale
Common Stock
[F1]2026-03-17$69.42/sh−3,125$216,938→ 93,979 total - Sale
Common Stock
[F1]2026-03-18$68.71/sh−3,610$248,043→ 90,369 total - Sale
Common Stock
[F1]2026-03-19$67.00/sh−4,589$307,463→ 85,780 total
- 475(indirect: By daughter)
Common Stock
[F2]
Footnotes (2)
- [F1]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- [F2]This holding balance is related to the Reporting Person's daughter who shares the Reporting Person's household. The Reporting Person disclaims beneficial ownership of the securities held by his daughter, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purposes.